Literature DB >> 17116128

Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency.

T P Baglin1, D Cousins, D M Keeling, D J Perry, H G Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17116128     DOI： 10.1111/j.1365-2141.2006.06379.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  20 in total

Review 1.  Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.

Authors:  Stefano Sivolella; Marleen De Biagi; Giulia Brunello; Mario Berengo; Vittorio Pengo
Journal:  Odontology       Date:  2015-02-06       Impact factor: 2.634

2.  Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays.

Authors:  Ying Li; Saeed A Jortani; Bronwyn Ramey-Hartung; Elizabeth Hudson; Bertrand Lemieux; Huimin Kong
Journal:  Clin Chim Acta       Date:  2010-09-18       Impact factor: 3.786

Review 3.  Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.

Authors:  Thomas P Moyer; Dennis J O'Kane; Linnea M Baudhuin; Carmen L Wiley; Alexandre Fortini; Pamela K Fisher; Denise M Dupras; Rajeev Chaudhry; Prabin Thapa; Alan R Zinsmeister; John A Heit
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

Review 4.  Optimal loading dose for the initiation of warfarin: a systematic review.

Authors:  Carl Heneghan; Sally Tyndel; Clare Bankhead; Yi Wan; David Keeling; Rafael Perera; Alison Ward
Journal:  BMC Cardiovasc Disord       Date:  2010-04-19       Impact factor: 2.298

5.  Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation.

Authors:  Susan I O'Shea; Murat O Arcasoy; Gregory Samsa; Sandra E Cummings; Elizabeth H Thames; Richard S Surwit; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2007-07-08       Impact factor: 2.300

6.  Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.

Authors:  Tim A Holt; Tina D Hunter; Candace Gunnarsson; Nada Khan; Paul Cload; Gregory Y H Lip
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386

7.  Prothrombin complex concentrate (Beriplex P/N).

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

8.  Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.

Authors:  Yun Wong
Journal:  Clin Med Insights Case Rep       Date:  2011-01-12

9.  A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.

Authors:  Leanne Stafford; Gregory M Peterson; Luke R E Bereznicki; Shane L Jackson
Journal:  BMC Health Serv Res       Date:  2011-01-25       Impact factor: 2.655

10.  Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model.

Authors:  Oliver Grottke; Rolf Rossaint; Yvonne Henskens; Rene van Oerle; Hugo Ten Cate; Henri M H Spronk
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.